Genocea Biosciences, Inc.
GNCA
GNCA was delisted on the 2nd of June, 2022.
39 hedge funds and large institutions have $77M invested in Genocea Biosciences, Inc. in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 9 closing their positions.
445% more call options, than puts
Call options by funds: $1.08M | Put options by funds: $198K
225% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
21% more capital invested
Capital invested by funds: $63.4M → $77M (+$13.6M)
0% more funds holding
Funds holding: 39 → 39 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
+$2.87M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.58M |
| 3 |
Renaissance Technologies
New York
|
+$422K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$404K |
| 5 |
Two Sigma Investments
New York
|
+$381K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$1.22M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$716K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$129K |
| 4 |
JJIJ
Johnson & Johnson Innovation - JJDC
New Brunswick,
New Jersey
|
-$99K |
| 5 |
Squarepoint
New York
|
-$59K |
GNCA Hedge Fund Activity: Q4 2020 in Review
39 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q4 2020, worth a combined $77M — up 21% from $63.4M a quarter earlier.
Fund positioning in GNCA was balanced in Q4 2020: 9 funds opened new positions, 9 closed out, 13 added to existing stakes and 4 trimmed.
The largest buyer was Kingdon Capital Management, adding an estimated $2.87M. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.22M sold.
- 39 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $77M of Genocea Biosciences, Inc. stock for Q4 2020, up 21% quarter-over-quarter.
- 9 funds opened new Genocea Biosciences, Inc. positions in Q4 2020 and 9 closed out, a net change of 0 holders.
- The largest Genocea Biosciences, Inc. buyer in Q4 2020 was Kingdon Capital Management, an estimated $2.87M added.
- The largest Genocea Biosciences, Inc. seller in Q4 2020 was AWM Investment Company, an estimated $1.22M sold.
Based on aggregated 13F filings for Q4 2020.